Neoangiogenesis may be most critical marker for melanoma patient prognosis

Washington - Ongoing research indicates neoangiogenesis may have a role as both a novel, powerful prognostic factor for melanoma and an important target for therapeutic strategies aiming to reduce the risk for metastasis, said Robert J. Friedman, M.D., M.Sc.

Related Videos
Related Content

The Connection Between COVID Lung Lesions and Skin Lesions

April 1st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Panel Questions Isotretinoin iPLEDGE REMS

March 31st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Photoprotection Can Improve Acne Outcomes

March 31st 2023

What's Trending in Skin Care: March 2023

March 31st 2023

The Connection Between COVID Lung Lesions and Skin Lesions

April 1st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Panel Questions Isotretinoin iPLEDGE REMS

March 31st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Photoprotection Can Improve Acne Outcomes

March 31st 2023

What's Trending in Skin Care: March 2023

March 31st 2023

The Connection Between COVID Lung Lesions and Skin Lesions

April 1st 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

FDA Panel Questions Isotretinoin iPLEDGE REMS

March 31st 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Photoprotection Can Improve Acne Outcomes

March 31st 2023

What's Trending in Skin Care: March 2023

March 31st 2023
© 2023 MJH Life Sciences

All rights reserved.